Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more...
The best live TV streaming services to cut cable in 2025
<p>Around ten years ago, as the price of cable rose to untenable heights, live TV streaming services <a data-i13n="cpos:1;pos:1" href="https://www.engadget.com/2015-02-09-sling [...]
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/80d83acceff64c4fc5851e3ab8f802f1.jpg"/><p>Sales of Novo Nordisk’s (<a cla [...]